Convergence Investment Partners, LLC Viatris Inc Transaction History

Convergence Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$10.05 - $12.02 $205,110 - $245,316	20,409 Added 38.96%	72,792 $773,000
Q1 2024 May 03, 2024	BUY	$11.27 - $13.53 $337,468 - $405,142	29,944 Added 133.45%	52,383 $625,000
Q4 2023 Feb 05, 2024	BUY	$8.77 - $10.85 $196,790 - $243,463	22,439 New	22,439 $243,000
Q1 2023 May 09, 2023	BUY	$9.2 - $12.26 $138,082 - $184,010	15,009 New	15,009 $144,000
Q2 2022 Aug 05, 2022	BUY	$9.95 - $12.27 $110,643 - $136,442	11,120 New	11,120 $116,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.